37 / 100
283
Ces Urol 2016; 20(4): 275–284
PŘEHLEDOVÝ ČLÁNEK
22. Longhurst PA, Wein AJ, Levin RM.
In vivo urinary bladder function in rats following prolonged diabetic
and non diabetic diuresis. Neurourol Urodyn 1990; 9: 171.
23. Satriano J.
Kidney growth, hypertrophy and the unifying mechanism of diabetic complications. Amino
Acids 2007; 33: 331.
24. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ.
Recent advances in understanding the biology
of diabetes associated bladder complications and novel therapy. BJU Int 2005; 95: 733.
25. Beshay E, Carrier S.
Oxidative stress plays role in diabetes induced bladder dysfunction in a rat model.
Urology 2004; 64: 1062–1067.
26. Kanika ND, Chang J, Tong Y, et al.
Oxidative stress status accompanying diabetic bladder cystopathy
results in the activation of protein degradation pathways. BJU Int 2011; 107: 1676–1684.
27. Changolkar AK, Hypolite JA, Disanto M, et al.
Diabetes induced decrease in detrusor smooth muscle
force is associated with oxidative stress and overactivity of aldose reductase. J Urol. 2005, 173: 309–313.
28. Tong YC, Cheng JT, Wan WC.
Effects of Ba-Wei-Die-Huang-Wan on the cholinergic function and
protein expression of M2 muscarinic receptor of the urinary bladder in diabetic rats. Neurosci Lett. 2002,
13; 330(1): 21–24.
29. Sun Y, Chai T.
Role of purinergic signaling in voiding dysfunction. Curr Bladder Dysfunction Rep. 2010;
5: 219.
30. Poladia DP, Bauer JA.
Early cell specific changes in nitric oxide synthases, reactive nitrogen species
formation, and ubiquitination during diabetes related bladder remodeling. Diabetes Metab Res Rev. 2003;
19: 313.
31. Christ GJ1, Bushman W, Fraser MO.
Impact of diabetes and obesity on the prostate and urethra:
Implications to improve bladder dysfunction understanding and treatment. J. Urol. 2009; 182: S38–44.
32. Liu G, Lin YH, Yamada Y, Daneshgari F.
External urethral sphincter activity in diabetic rats. Neurourol
Urodyn. 2008; 27: 429–434.
33. Yang Z, Dolber PC, Fraser MO.
Diabetic urethropathy compounds the effects of diabetic cystopathy.
J Urol. 2007; 178: 2213–2219.
34. Changxiao H, Zhengyong Y, Shibing Y.
Clinical and urodynamic evaluation of women referred with
diabetes mellitus. Int. Urogynecol. J. 2014; 25: 979–983.
35. Zderic SA, Chacko S, DiSanto M, Wein AJ.
Voiding function: relevant anatomy, physiology, pharma‑
cology, and molecular aspects. In: Adult and Pediatric Urology, 4
th
ed. Edited by J Gillenwater, J Grayhack,
S Howards et al. Philadelphia: Lippincott 2002; 1061–1114.
36. Kaplan SA, Te AE and Blaivas JG.
Urodynamic findings in patients with diabetic cystopathy. J Urol
1995; 153: 342.
37. Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ.
Effects of diabetes on female voiding behavior, J Urol.
2004; 172: 989–992.
38. Nakayama H, Jørgensen HS, Pedersen PM, Raaschou HO, Olsen TS.
Prevalence and risk factors of
incontinence after stroke. The Copenhagen Stroke Study. Stroke. 1997; 28: 58.
39. Lifford KL, Curhan GC, Hu FB, Barbieri RL, Grodstein F.
Type 2 diabetes mellitus and risk of developing
urinary incontinence. J Am Geriatr. Soc. 2005; 53: 1851.
40. Brown JS, Vittinghoff E, Lin F, Nyberg LM, Kusek JW, Kanaya AM.
Prevalence and risk factors for urinary
incontinence in women with type 2 diabetes and impaired fasting glucose: findings from the National
Health and Nutrition Examination Survey 2001–2002. Diabetes Care 2006; 29: 1307.
41. James R, Hijaz A.
Lower urinary tract symptoms in women with diabetes mellitus: A Current Review,
Curr Urol Rep, 2014; 15: 440.
42. Daneshgari F, Liu G, Imrey PB.
Time dependent changes in diabetic cystopathy in rats include com‑
pensated and decompensated bladder function. J Urol. 2006; 176: 380–386.